Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Xiao (Chengdu, China), J. Fu (Chengdu, China), S. Wang (Chengdu, China), Y. Wang (Chengdu, China), T. Miao (Chengdu, China), B. Mao (Chengdu, China). Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD. 5246

Member's Comments

No comment yet.

Related content which might interest you: The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1 Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Elevated expression of the NLRP3 inflammasome in neutrophilic asthma Source: Eur Respir J 2014; 43: 1067-1076 Year: 2014 Caspase-1 pathway in COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019 Year: 2020 In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020 Year: 2020 Late Breaking Abstract - 17-oxo-DHA inhibits the NLRP3 inflammasome downstream of mitochondrial ROS and ERK pathway Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Activation of IL-32 pathway in COPD Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Role of NLRP3 inflammasome and ATP in S100A12-induced MUC5AC production in airway epithelial cells Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung Source: Eur Respir J 2016; 47: 910-918 Year: 2016 Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011